Hanmi Science Co (008930.KS) Akcie Kurz
Hanmi Science Co Kurz
Tržby rostly o 6,0 % ročně za posledních 19 let na 1,36 Mld. KRW. Zisk na akcii rostl o 2,6 % ročně za posledních 19 let. čistá marže společnosti Hanmi Science Co je nyní 8,7 %, nahoru z 4,5 % před několika lety. Hanmi Science Co aktuálně nabízí dividendový výnos kolem 0,69 %. Výplatní poměr je kolem 32 % zisku.
Cena akcie Hanmi Science Co
Tato data přes Eulerpool API
100 000 požadavků/měs. zdarma · bez karty
Obchodní model Hanmi Science Co a analýza akcií
Nejčastější otázky týkající se akcie Hanmi Science Co
The business model of Hanmi Science Co Ltd., a South Korean company, revolves around its expertise in the field of biotechnology. Hanmi Science focuses on the development, manufacturing, and distribution of innovative pharmaceutical products. The company is committed to researching and creating cutting-edge drugs and therapies to address various medical conditions and improve patient outcomes. With a strong emphasis on research and development, Hanmi Science aims to enhance global healthcare by delivering novel treatment options to customers worldwide.
Hanmi Science Co Ltd is primarily active in the pharmaceutical and healthcare industries.
Hanmi Science Co Ltd faces competition from various companies in the market. Some of its main competitors include CJ Healthcare Corp, SK Biopharmaceuticals Co Ltd, and Yuhan Corporation. These competitors are also prominent players in the pharmaceutical and biotechnology industry.
Hanmi Science Co Ltd is a leading company in the healthcare industry. Established in 1973, Hanmi Science Co Ltd has a rich history of over four decades. The company focuses on research, development, and manufacturing of innovative medical devices and pharmaceutical products. With a strong commitment to improving global healthcare, Hanmi Science Co Ltd has made significant contributions to the industry. They have formed strategic partnerships and collaborations with renowned companies to enhance their capabilities and expand their global presence. Hanmi Science Co Ltd's dedication to quality, innovation, and customer satisfaction has positioned them as a trusted and reliable name in the healthcare sector.
Hanmi Science Co Ltd has achieved several significant milestones in its corporate history. The company made its debut in 1973 as a small chemical trading business and has since evolved into a leading global provider of pharmaceutical and healthcare solutions. Hanmi Science Co Ltd successfully developed and launched its first original drug, LUSEDRA, in 2008, marking a major advancement in the pharmaceutical sector. Additionally, the company has established numerous strategic partnerships and collaborations with global pharmaceutical giants, enabling it to enhance its research and development capabilities. Hanmi Science Co Ltd continues to foster innovation, expand its product pipeline, and deliver breakthrough treatments to improve patient outcomes.
Hanmi Science Co Ltd is primarily present in South Korea.
Hanmi Science Co Ltd represents values of innovation, excellence, and customer satisfaction. With a strong corporate philosophy focused on pioneering new technologies and providing top-notch services, Hanmi Science Co Ltd aims to meet the ever-evolving needs of its clients. By prioritizing research and development, the company strives to deliver cutting-edge solutions in the fields of biotechnology and pharmaceuticals. With a commitment to ethical practices, Hanmi Science Co Ltd also emphasizes integrity and social responsibility in its operations. Through its dedication to these values and its forward-thinking approach, Hanmi Science Co Ltd continues to make significant contributions to the industry.
Při aktuálním kurzu se akcie Hanmi Science Co obchoduje za 28,90 EUR (43 500,00 KRW).
Akcie Hanmi Science Co (008930.KS) je kótována na 1 burzách, mimo jiné: KOSPI (Seoul) (008930.KS).
Hanmi Science Co Ltd is a leading company in the pharmaceutical industry that specializes in the research and development of innovative drugs and medical devices. The company offers a wide range of products and services divided into various business areas.
Tržby nelze pro Hanmi Science Co aktuálně vypočítat.
Zisk nelze pro Hanmi Science Co aktuálně vypočítat.
Poměr P/E nelze pro Hanmi Science Co aktuálně vypočítat.
Poměr P/S nelze pro Hanmi Science Co aktuálně vypočítat.
Score kvality pro Hanmi Science Co je 4/10.
ISIN Hanmi Science Co je KR7008930000. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
Ticker Hanmi Science Co je 008930.KS. Symbol tickeru se používá k obchodování akcií Hanmi Science Co na burze.
Hanmi Science Co akcie
Hanmi Science Co Peer Group
Hanmi Science Co Ticker
Hanmi Science Co FIGI
Všechny fundamentální údaje o Hanmi Science Co v podrobné analýze
Naše analýzy akcií společnosti Hanmi Science Co zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Hanmi Science Co. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: